Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

Schirmer, Lucas, Hoornaert, Chloé, Le Blon, Debbie, Eigel, Dimitri, Neto, Catia, Gumbleton, Mark ORCID: https://orcid.org/0000-0002-7386-311X, Welzel, Petra B., Rosser, Anne E. ORCID: https://orcid.org/0000-0002-4716-4753, Werner, Carsten, Ponsaerts, Peter and Newland, Ben 2020. Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain. Biomaterials Science 8 (18) , pp. 4997-5004. 10.1039/D0BM01249A

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (3MB) | Preview

Abstract

Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Pharmacy Schools > Biosciences Research Institutes & Centres > Neuroscience and Mental Health Research Institute (NMHII) Schools > Medicine
Publisher:	Royal Society of Chemistry
ISSN:	2047-4830
Funders:	Wellcome Trust
Date of First Compliant Deposit:	28 September 2020
Date of Acceptance:	1 September 2020
Last Modified:	03 May 2024 01:05
URI:	https://orca.cardiff.ac.uk/id/eprint/135174

Citation Data

Cited 10 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item